|22nd September 2020||Robyn Hunter||28,450||Open or private sale||$4.38||$124,611.00|
|26th August 2020||Malcolm Hoenlein||16,667||Open or private purchase||$18.00||$300,006.00|
|26th August 2020||Lindsay A Md Rosenwald||52,500||Open or private purchase||$18.00||$945,000.00|
|14th July 2020||Lindsay A Md Rosenwald||16,611||Grant/award etc.||$0.00|
|14th July 2020||Michael S Weiss||16,611||Grant/award etc.||$0.00|
|22nd June 2020||Michael S Weiss||1,556,029||Grant/award etc.||$0.00|
|5th June 2020||Michael S Weiss||24,390||Grant/award etc.||$0.00|
|5th June 2020||Lindsay A Md Rosenwald||24,390||Grant/award etc.||$0.00|
|3rd June 2020||Eric K Rowinsky||890||Grant/award etc.||$0.00|
|1st January 2020||Lindsay A Md Rosenwald||801,536||Grant/award etc.||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 5/10.
Fortress Biotech, Inc. engages in the development and commercialization of novel pharmaceutical and biotechnology products. It operates through the following segments: Dermatology Product Sales, Pharmaceutical and Biotechnology Product Development, and National. The National segment consists of National Holdings Corporation.